Cargando…

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis

BACKGROUND: Hypertriglyceridemia (HTG) is considered an independent risk factor for major adverse cardiovascular events (MACE). METHODS: This study analyzed the effects of various agents on MACE risk reduction in HTG (serum triglyceride ≥ 150 mg/dl) populations by performing a network meta-analysis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yan-yan, Yan, Li, Wang, Zhong-min, Wang, Xi, Meng, Hua, Li, Wen-bo, Chen, Dong-chang, Li, Meng, Liu, Jun, An, Song-tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845128/ https://www.ncbi.nlm.nih.gov/pubmed/33514420 http://dx.doi.org/10.1186/s13098-021-00626-7

Ejemplares similares

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

Roles of ST2, IL‐33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention
por: Wang, Yan‐Peng, et al.
Publicado: (2017)

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
por: Sahlberg, Marie, et al.
Publicado: (2015)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: Results from the 4C cohort study
por: Pan, Limeng, et al.
Publicado: (2023)

Prediction models for major adverse cardiovascular events following ST-segment elevation myocardial infarction and subgroup-specific performance
por: Chen, Weiyao, et al.
Publicado: (2023)

Hypertriglyceridemia and Cardiovascular Diseases: Revisited
por: Han, Seung Hwan, et al.
Publicado: (2016)

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
por: Tenenbaum, Alexander, et al.
Publicado: (2014)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020)

The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis
por: Murad, M Hassan, et al.
Publicado: (2012)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Effect of Heart Rate on Major Adverse Cardiovascular Events in Hypertensive Patients with Different Ages and Genders
por: Xi, Yang, et al.
Publicado: (2021)

Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes
por: Kim, Duhoe, et al.
Publicado: (2022)

Risk factors for major adverse cardiovascular events after coronary artery bypass grafting using radial artery grafts
por: Xia, Tianyu, et al.
Publicado: (2023)

The relationship between neutrophil-to-lymphocyte ratio and major cardiovascular events in elderly patients with chronic heart failure
por: Yan, Wei, et al.
Publicado: (2017)

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Yang, Jie, et al.
Publicado: (2022)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Novel endoscopic papillectomy for reducing postoperative adverse events (with videos)
por: Jiang, Lei, et al.
Publicado: (2020)

Metabolomics-Based Clinical Efficacy and Effect on the Endogenous Metabolites of Tangzhiqing Tablet, a Chinese Patent Medicine for Type 2 Diabetes Mellitus with Hypertriglyceridemia
por: Liu, Jia, et al.
Publicado: (2018)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
por: Nelson, Adam J., et al.
Publicado: (2022)

Machine learning prediction of postoperative major adverse cardiovascular events in geriatric patients: a prospective cohort study
por: Peng, Xiran, et al.
Publicado: (2022)

Sex differences in major adverse cardiovascular and cerebrovascular event risk among central retinal artery occlusion patients
por: Chen, Ting, et al.
Publicado: (2023)

Grade 3 Echocardiographic Diastolic Dysfunction Is Associated With Increased Risk of Major Adverse Cardiovascular Events After Surgery: A Retrospective Cohort Study
por: Zhou, Yan, et al.
Publicado: (2019)

Hypertriglyceridemia in female rats during pregnancy induces obesity in male offspring via altering hypothalamic leptin signaling
por: Rahman, Tanzil Ur, et al.
Publicado: (2017)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Major adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardiovascular magnetic resonance
por: Rydman, Riikka, et al.
Publicado: (2018)

Hypertriglyceridemia and atherosclerosis
por: Peng, Jia, et al.
Publicado: (2017)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

CHADS(2) Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's Syndrome
por: Wang, Yuh-Feng, et al.
Publicado: (2014)

A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data
por: Sun, Qinliang, et al.
Publicado: (2022)

Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events
por: Luo, Jun-Yi, et al.
Publicado: (2022)

Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis
por: Li, Lin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vobhb47trejsmvtvdbdiuissfv